osteoporosis

A ground-breaking new study has succeeded in compiling an “atlas” of genetic factors that are associated with estimated bone mineral density, one of the most clinically relevant factors in diagnosing osteoporosis.

A significantly reduced risk of bone fractures among post-menopausal women with severe osteoporosis has been reported, following a clinical trial that was conducted, in part, at the JGH.

The largest study ever conducted on the genetics of common, age-related bone disease has resulted in the identification of 153 new gene variants associated with the loss of bone mineral density, the strongest clinical risk factor for osteoporosis and a frequent cause of fractures.

In the space of just a few months this past spring, Dr. Gerald Batist was appointed a Member of the Order of Canada and a Knight of the National Order of Quebec.

One of Hope & Cope’s newest initiatives, the Breast & Bone Health Program, identifies women who have had breast cancer and are at risk for bone fragility.